Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
Eli S. Rosenberg, James M. Tesoriero, Elizabeth M. Rosenthal, et al.
Annals of Epidemiology (2020) Vol. 48, pp. 23-29.e4
Open Access | Times Cited: 268

Showing 26-50 of 268 citing articles:

Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City
Daniel Stadlbauer, Jessica Tan, Kaijun Jiang, et al.
Nature (2020) Vol. 590, Iss. 7844, pp. 146-150
Open Access | Times Cited: 149
Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys
Frederick J. Angulo, Lyn Finelli, David L. Swerdlow
JAMA Network Open (2021) Vol. 4, Iss. 1, pp. e2033706-e2033706
Open Access | Times Cited: 138
Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
Heather Kalish, Carleen Klumpp‐Thomas, Sally Hunsberger, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 601
Open Access | Times Cited: 132
How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19
Emma K. Accorsi, Xueting Qiu, Éva Rumpler, et al.
European Journal of Epidemiology (2021) Vol. 36, Iss. 2, pp. 179-196
Open Access | Times Cited: 121
Reconciling estimates of global spread and infection fatality rates of COVID‐19: An overview of systematic evaluations
John P. A. Ioannidis
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 5
Open Access | Times Cited: 120
Assessing racial and ethnic disparities using a COVID-19 outcomes continuum for New York State
David R. Holtgräve, Meredith A. Barranco, James M. Tesoriero, et al.
Annals of Epidemiology (2020) Vol. 48, pp. 9-14
Open Access | Times Cited: 132
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020
Holly M. Biggs, Jennifer B. Harris, Lucy Breakwell, et al.
MMWR Morbidity and Mortality Weekly Report (2020) Vol. 69, Iss. 29, pp. 965-970
Open Access | Times Cited: 120
Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States
Justin D. Silverman, Nathaniel Hupert, Alex Washburne
Science Translational Medicine (2020) Vol. 12, Iss. 554
Open Access | Times Cited: 115
Covid-19: Do many people have pre-existing immunity?
Peter Doshi
BMJ (2020), pp. m3563-m3563
Closed Access | Times Cited: 103
Estimation of the fraction of COVID-19 infected people in U.S. states and countries worldwide
Jungsik Noh, Gaudenz Danuser
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0246772-e0246772
Open Access | Times Cited: 97
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
David Simón, Koray Taşçılar, Gerhard Krönke, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 88
Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19
Mathias Peirlinck, Kevin Linka, Francisco Sahli Costabal, et al.
Computer Methods in Applied Mechanics and Engineering (2020) Vol. 372, pp. 113410-113410
Open Access | Times Cited: 78
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts
Vivek Naranbhai, Christina C. Chang, Wilfredo F. Garcia Beltran, et al.
The Journal of Infectious Diseases (2020) Vol. 222, Iss. 12, pp. 1955-1959
Open Access | Times Cited: 77
On the effect of age on the transmission of SARS-CoV-2 in households, schools and the community
E. J. C. Goldstein, Marc Lipsitch, Müge Çevik
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 73
Seroprevalence of Antibodies to SARS-CoV-2 in Six Sites in the United States, March 23-May 3, 2020
Fiona P. Havers, Carrie Reed, Travis Lim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 71
Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies
Daniel Herrera, Gustavo de los Campos
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 64
Death Toll of COVID-19 on Asian Americans: Disparities Revealed
Brandon W. Yan, Andrea Hwang, Fiona Ng, et al.
Journal of General Internal Medicine (2021) Vol. 36, Iss. 11, pp. 3545-3549
Open Access | Times Cited: 63
Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa
Jane Shaw, Maynard Meiring, Tracy Cummins, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0247852-e0247852
Open Access | Times Cited: 56
Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-analysis, & Public Policy Implications
Andrew Levin, William P. Hanage, Nana Owusu‐Boaitey, et al.
(2020)
Open Access | Times Cited: 65
Regional variation in COVID-19 disparities: connections with immigrant and Latinx communities in U.S. counties
Kate W. Strully, Tse‐Chuan Yang, Han Liu
Annals of Epidemiology (2020) Vol. 53, pp. 56-62.e2
Open Access | Times Cited: 64
SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May–June 2020
Lara J. Akinbami, Nga Vuong, Lyle R. Petersen, et al.
Emerging infectious diseases (2020) Vol. 26, Iss. 12, pp. 2863-2871
Open Access | Times Cited: 62
High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris
François Anna, Sophie Goyard, Ana I. Lalanne, et al.
European Journal of Immunology (2020) Vol. 51, Iss. 1, pp. 180-190
Open Access | Times Cited: 62
Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications
Andrew Levin, William P. Hanage, Nana Owusu‐Boaitey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 61
Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19
Mina Psichοgiou, Andreas Karabinis, Ioanna D. Pavlopoulou, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0243025-e0243025
Open Access | Times Cited: 59
Age-specific mortality and immunity patterns of SARS-CoV-2 infection in 45 countries
Megan O’Driscoll, Gabriel Ribeiro dos Santos, Lin Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 58

Scroll to top